Skip to main content

Animations

MJFF Publications

1631 - 1640 of 9145 Results
Title
Year
  • Year
  • 2026
  • 2026
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2026
  • 2021
  • 2020
  • Summary Details
    OPEN
    Title: Genome-wide association and population-tailored polygenic risk for Parkinson’s disease in Taiwan
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-026-01349-0
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Tolerability and efficacy of full-body head-up tilt sleeping in Parkinson’s disease and multiple system atrophy
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-026-01359-y
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Development and Application of High-Throughput Single Cell Lipid Profiling: A Study of SNCA-A53T Human Dopamine Neurons
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.isci.2020.101703
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Constipation and sleep behaviour disorder associate with processing speed and attention in males with Parkinson’s disease over five years follow-up
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-020-75800-4
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Investigation of Somatic Mutations in Human Brains Targeting Genes Associated With Parkinson's Disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2020.570424
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Exosome markers of LRRK2 kinase inhibition
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-020-00138-7
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-020-00134-x
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Novel VARS1 variants define new clinical and molecular subtypes of a rare neurodevelopmental syndrome
    Journal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.bbadis.2026.168184
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical Practice
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2021/2603641
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Validation of human microRNA target pathways enables evaluation of target prediction tools
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/nar/gkaa1161
    Citation Count: 70
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.